Clinical trial reportThe Lancet. Infectious diseasesPublished
Efficacy, safety, and immunogenicity of a nine-valent vaccine (ExPEC9V) for the prevention of invasive Escherichia coli disease in older adults: a phase 3, randomised, placebo-controlled trial (E.mbrace)
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Mercer County
Publication record
- Type
- Clinical trial report
- Venue
- The Lancet. Infectious diseases
- Published
- Topic
- Clinical care
- PubMed ID
- 42863477
- Added to directory
- Source checked